NO163056C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo (3,4-d) - pyridin-3-on-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo (3,4-d) - pyridin-3-on-derivater.

Info

Publication number
NO163056C
NO163056C NO852747A NO852747A NO163056C NO 163056 C NO163056 C NO 163056C NO 852747 A NO852747 A NO 852747A NO 852747 A NO852747 A NO 852747A NO 163056 C NO163056 C NO 163056C
Authority
NO
Norway
Prior art keywords
lower alkyl
preparation
optionally substituted
receptor modulators
pyridin
Prior art date
Application number
NO852747A
Other languages
English (en)
Other versions
NO163056B (no
NO852747L (no
Inventor
Naokata Yokoyama
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO852747L publication Critical patent/NO852747L/no
Publication of NO163056B publication Critical patent/NO163056B/no
Publication of NO163056C publication Critical patent/NO163056C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO852747A 1984-07-09 1985-07-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo (3,4-d) - pyridin-3-on-derivater. NO163056C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62870384A 1984-07-09 1984-07-09

Publications (3)

Publication Number Publication Date
NO852747L NO852747L (no) 1986-01-10
NO163056B NO163056B (no) 1989-12-18
NO163056C true NO163056C (no) 1990-03-28

Family

ID=24519969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852747A NO163056C (no) 1984-07-09 1985-07-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo (3,4-d) - pyridin-3-on-derivater.

Country Status (18)

Country Link
EP (1) EP0168350B1 (no)
JP (1) JPS6140285A (no)
AT (1) ATE75744T1 (no)
AU (1) AU584906B2 (no)
CA (1) CA1263651A (no)
DD (1) DD238235A5 (no)
DE (1) DE3585973D1 (no)
DK (1) DK168952B1 (no)
ES (2) ES8703462A1 (no)
FI (1) FI80695C (no)
GR (1) GR851685B (no)
HU (1) HU198929B (no)
IE (1) IE58743B1 (no)
IL (1) IL75745A (no)
NO (1) NO163056C (no)
NZ (1) NZ212669A (no)
PT (1) PT80777B (no)
ZA (1) ZA855126B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
DE3781249T2 (de) * 1986-11-25 1992-12-17 Ciba Geigy Ag Einige cycloalka(b)pyrazolo(3,4-d)pyridin-3-on-derivate.
AU609808B2 (en) * 1987-04-09 1991-05-09 E.I. Du Pont De Nemours And Company Insecticidal substituted indazoles
US5378848A (en) * 1992-02-12 1995-01-03 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
GB9713707D0 (en) * 1997-06-27 1997-09-03 Merck Sharp & Dohme Therapeutic agents
AR127972A1 (es) * 2021-12-17 2024-03-13 Pi Industries Ltd Novedosos compuestos de piridina carboxamida bicíclica sustituida fusionada para combatir hongos fitopatogénicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3068673D1 (en) * 1979-06-21 1984-08-30 Ciba Geigy Ag Pyrazolo-quinolines, processes for their production, and pharmaceutical compositions containing them
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
US4479955A (en) * 1983-01-10 1984-10-30 Ciba-Geigy Corporation Heterocycle-fused pyrazolo[3,4-d]pyridin-3-ones as benzodiazepine receptor modulators
EP0126970A3 (en) * 1983-04-27 1985-11-06 Beecham Group Plc Anxiolytic and anti-depressant thienopyridine derivatives

Also Published As

Publication number Publication date
ZA855126B (en) 1987-03-25
PT80777B (pt) 1987-10-20
AU584906B2 (en) 1989-06-08
EP0168350A2 (en) 1986-01-15
ATE75744T1 (de) 1992-05-15
NZ212669A (en) 1989-04-26
EP0168350B1 (en) 1992-05-06
ES8706674A1 (es) 1987-07-01
DE3585973D1 (de) 1992-06-11
IE851712L (en) 1986-01-09
ES544954A0 (es) 1987-02-16
HU198929B (en) 1989-12-28
HUT38632A (en) 1986-06-30
IE58743B1 (en) 1993-11-03
FI852672A0 (fi) 1985-07-05
JPS6140285A (ja) 1986-02-26
NO163056B (no) 1989-12-18
EP0168350A3 (en) 1987-09-09
NO852747L (no) 1986-01-10
ES8703462A1 (es) 1987-02-16
DK310785A (da) 1986-01-10
FI852672L (fi) 1986-01-10
DD238235A5 (de) 1986-08-13
PT80777A (en) 1985-08-01
DK168952B1 (da) 1994-07-18
AU4467585A (en) 1986-01-16
FI80695B (fi) 1990-03-30
FI80695C (fi) 1990-07-10
CA1263651A (en) 1989-12-05
DK310785D0 (da) 1985-07-08
ES551992A0 (es) 1987-07-01
IL75745A0 (en) 1985-11-29
GR851685B (no) 1985-11-26
IL75745A (en) 1989-05-15

Similar Documents

Publication Publication Date Title
DK202882A (da) Fremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater
NO165343C (no) Analogifremgangsmaate til fremstilling av nye, terapeutiskaktive 3-(2-aminoetyl)indoler.
CA3191362A1 (en) Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof
HUT44771A (en) Process for producing 3-aminodihydro-benzo/b/pyran and benzothiopyran derivatives and pharmaceutical preparation comprising them as active substance
HUP0204162A2 (hu) Spiro[2H-1-benzopirán-2,4'-piperidin]-származékok, mint glicin transzport inhibitorok és ezeket tartalmazó gyógyszerkészítmények
NO163056C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo (3,4-d) - pyridin-3-on-derivater.
HK1004750A1 (en) Bicyclic sulfonamide derivatives and their preparation their use and formulations containing them
OA07450A (fr) Nouveaux dérivés du thioformamide, leur préparation et les médicaments qui les contiennent.
PT1178047E (pt) Derivados diazabiciclooctano e seus usos terapeuticos
NO157578C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazo(1,2-a)kinolinderivater
DK0388081T3 (da) Middel til behandling af sygdomme i det cerebrale neurotransmissionssystem
ATE79625T1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indol-1-essigs|uren.
NO166586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cykloalka-(b)-pyrazolo(3,4-d)-pyrridin-3-on-derivater.
ES2064692T3 (es) Nuevos derivados de la 2-acetidinona 1,3,4-trisustituidas y su procedimiento de sintesis asimetrica.